Max Robotics — Global Service Robot Directory + US Certification

About

Paolo Parma is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive techniques for kidney and bladder cancer treatment. His major contributions lie in comparing open, laparoscopic, and robotic-assisted surgeries, with a particular focus on partial nephrectomy for small renal masses. Parma led the CLOCK II Laparoscopic Study, a landmark randomized trial comparing on-clamp versus off-clamp laparoscopic partial nephrectomy, which has garnered 19 citations and helped clarify perioperative outcomes. He also co-authored a cross-analysis of two RCTs comparing pure laparoscopic to robot-assisted approaches during off-clamp partial nephrectomy, further refining surgical decision-making. His multi-institutional study on laparoscopic and robotic ureteral stenosis repair (39 citations) established long-term follow-up data for this challenging procedure. With over 130 cumulative citations, Parma’s research has directly influenced urologic practice, particularly through his work on the Italian Radical Cystectomy Registry, which tracks outcomes for over 1,400 bladder cancer patients. His studies on perioperative safety during the COVID-19 pandemic also provided critical national-level data. Parma’s systematic, evidence-based approach continues to shape the evolution of urologic oncology surgery.